At a Glance
- Tasks: Lead clinical development programs and oversee trials in RNAi therapeutics.
- Company: Alnylam Pharmaceuticals, a leader in innovative drug development.
- Benefits: Hybrid work model, competitive salary, and opportunities for professional growth.
- Other info: Collaborative environment with a focus on diverse disease areas.
- Why this job: Make a real impact in neurodegeneration therapies and drive regulatory approvals.
- Qualifications: Imaginative physician with experience in clinical research and drug development.
The predicted salary is between 80000 - 100000 £ per year.
Alnylam Pharmaceuticals is seeking an imaginative physician drug developer to provide clinical leadership in RNAi therapeutics across diverse disease areas.
The Sr.
Director, Clinical Research will lead clinical development programs, interact with external experts, and influence strategies in a matrix organization.
Hybrid role at Cambridge, MA or Maidenhead, UK.
The role emphasizes driving regulatory approvals, overseeing trials, and collaborating with Research, Preclinical, Regulatory Affairs,
#J-18808-Ljbffr
Neurodegeneration Clinical Lead for RNAi Therapeutics in Maidenhead employer: Alnylam Pharmaceuticals
As an Associate Director in Brand Marketing for Rare Diseases, you will join a dynamic and innovative team dedicated to improving patients' lives through strategic marketing initiatives. Our company fosters a collaborative work culture that values employee growth, offering opportunities for professional development and the chance to make a meaningful impact in the rare disease space. Located in a vibrant international setting, we provide a supportive environment where your contributions are recognised and rewarded, making us an excellent employer for those seeking a fulfilling career in the pharmaceutical industry.
